A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

Name: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Published: 2025
License: Public Domain

Vividion Therapeutics, Inc. · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

kras ras

advanced solid tumors, ras, pi3k, kras, mek, phase i, solid tumors, kras g12c, her2, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

Related documents